SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point to sell Caplin Point Laboratories Colombia SAS to Caplin Point Far East

29 Mar 2023 Evaluate

Caplin Point Laboratories has entered into a Share Purchase agreement on March 28, 2023 for the sale of Caplin Point Laboratories Colombia SAS - Colombia, a subsidiary of the Company to Caplin Point Far East, Hong Kong, a wholly owned subsidiary of the Company.

Pursuant to execution of the Share Purchase Agreement and transfer of shares, Caplin Point Laboratories Colombia SAS - Colombia will cease to be a subsidiary of the company and shall become a step down subsidiary of the Company through Caplin Point Far East, Hong Kong.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×